✦ LIBER ✦

Treatment of severe refractory autoimmune hemolytic anemia in B-cell chronic lymphocytic leukemia with alemtuzumab (humanized CD52 monoclonal antibody)

✍ Scribed by Karlsson, C; Hansson, L; Celsing, F; Lundin, J

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of severe autoimmune hemolytic

✍ Royer, B; Vaida, I; Etienne, A; Garidi, R; Damaj, G; Marolleau, J P 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 78 KB

Efficacy and safety of low-dose alemtuzu

✍ Laurenti, L; Tarnani, M; Efremov, D G; Chiusolo, P; De Padua, L; Sica, S; Leone, 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 82 KB

The successful treatment of refractory a

✍ Gülsüm Emel Pamuk; Burhan Turgut; Muzaffer Demir; Fatma Tezcan; Özden Vural 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB 👁 2 views

Reconstitution of the T-cell repertoire

✍ Mohammad Reza Rezvany; Mahmood Jeddi Tehrani; Claes Karlsson; Jeanette Lundin; H 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 355 KB

Human/mouse radiation chimera generated

✍ Marcus, H; Shimoni, A; Ergas, D; Canaan, A; Dekel, B; Ben-David, D; David, M; Si 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 392 KB

Reply to ‘Efficacy and safety of low-dos

✍ Lundin, J 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 53 KB